HIV/AIDS Therapy
Cancer center receives grant for HIV/AIDS vaccine therapy
Published in Biotech Business Week, March 15th, 2004
The University of Texas M.D. Anderson Cancer Center has received notice of a grant from the U.S. National Institutes of Health (NIH) in excess of $1.3 million, as a continuation of earlier grants from the National Institute of Allergy and Infectious Diseases (NIAID), to further develop EradicAide vaccine technology for treatment of HIV/AIDS. The principal investigator is Jagan Sastry, an Associate professor in the Department of Immunology with a joint appointment in the Department of Veterinary Sciences at MD Anderson. EradicAide vaccine technology is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Information Technology
Biometric products permit remote acquisition, management of patients' data - Liver Cancer
Some normal human hepatocytes undergo apoptosis mediated by TRAIL-R1 and R2 - Contraception
FDA extends Plan B emergency contraceptive PDUFA date - Epilepsy
Licensing agreement signed for Rufinamide - Purchasing Agreements
Novation signs agreement for blood-gas analyzers - Sports Medicine Trends
Kids, older boomers driving $3B first aid and sports medicine markets - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
